US pharmacy pricing
Zinplava Cost Without Insurance — US Pharmacy Price Guide
Lowest price found · US pharmacies
$3,718.40/fill
for Zinplava, across the pharmacies in our data
US pharmacy prices — 40ml of 1000mg/40ml
| Pharmacy | Discount-card price | Regular cash price | Average retail |
|---|---|---|---|
| $3,718.40Lowest | $3,721.40 | $121.99 | |
| $3,718.40Lowest | $3,721.40 | $121.99 | |
| $3,871.84 | $3,874.84 | $121.99 | |
| $3,902.55 | $3,905.55 | $121.99 | |
| $3,926.60 | $3,929.60 | $121.99 | |
| $3,992.51 | $3,995.51 | $121.99 | |
| $3,992.51 | $3,995.51 | $121.99 | |
| $4,014.80 | $4,017.80 | $121.99 |
"Discount-card price" reflects a standard prescription discount card, not insurance. Prices change often — confirm at the pharmacy before filling.
Interchangeable forms
Per RxNorm (U.S. National Library of Medicine), these share the same active ingredient and strength as Zinplava.
Frequently asked questions
What's the cash price for Zinplava (Zinplava) in the US?
At the US pharmacies in our data, the lowest listed discount-card price for Zinplava is around $3,718.40. Prices vary by pharmacy, dosage, and pack size, so use the table above to compare specific options near you.
Is a generic version of Zinplava available?
Generic and brand-name pricing for Zinplava is broken out in the tables above where both exist in our data. Generic versions are typically the lower-cost option, but availability depends on the specific formulation and dosage.
How is the cost of Zinplava determined with insurance?
The out-of-pocket expense for Zinplava under an insurance plan varies based on your specific policy's formulary, deductible, and copay/coinsurance structure. For precise pricing details, contact your insurance provider directly. For those without coverage or with high cost-sharing, exploring available savings options can help manage the expense.
Is a generic version of Zinplava available?
No, Zinplava is a brand-name drug produced by Merck, and there is no FDA-approved generic alternative (bezlotoxumab) available at this time.
What is Zinplava and how is it used?
Zinplava (bezlotoxumab) is an FDA-approved monoclonal antibody prescription drug. It is used as an add-on treatment to antibiotic therapy for *Clostridioides difficile* infection (CDI) in adults. It works by binding to and neutralizing toxin B produced by the C. difficile bacteria, which helps reduce the risk of recurrent infection. Importantly, Zinplava is not an antibiotic and does not kill the bacteria; it must be used concurrently with antibacterial medication. The drug is administered as a single-dose intravenous infusion over approximately 60 minutes in a clinical setting. Patients with congestive heart failure should discuss this with their doctor before treatment, as safety considerations apply. Zinplava is not approved for use in individuals under 18 years of age. Always review all provided patient information and consult your healthcare provider with any questions.